**Core Concept**
HMG-CoA (3-Hydroxy-3-Methylglutaryl-Coenzyme A) is a key intermediate in the metabolism of cholesterol and ketone bodies. It is a crucial molecule in the regulation of cholesterol biosynthesis and ketogenesis.

**Why the Correct Answer is Right**
HMG-CoA is a product of the condensation of acetoacetyl-CoA and acetyl-CoA, and it is further converted to mevalonate by the enzyme HMG-CoA reductase. This enzyme is the target of statins, a class of cholesterol-lowering medications. The conversion of HMG-CoA to mevalonate is a critical step in the biosynthesis of cholesterol and isomerization of HMG-CoA to mevalonate is catalyzed by the enzyme HMG-CoA reductase.

**Why Each Wrong Option is Incorrect**
**Option A:** Glycolysis - HMG-CoA is not an intermediate in glycolysis, which is a pathway that converts glucose to pyruvate.
**Option B:** Pentose Phosphate Pathway - HMG-CoA is not involved in the pentose phosphate pathway, which generates NADPH and pentoses from glucose-6-phosphate.
**Option C:** Citric Acid Cycle - HMG-CoA is not an intermediate in the citric acid cycle, also known as the Krebs cycle or tricarboxylic acid cycle.

**Clinical Pearl / High-Yield Fact**
Statins, which inhibit HMG-CoA reductase, are widely used to lower cholesterol levels and prevent cardiovascular disease. They work by reducing the synthesis of cholesterol in the liver, which leads to increased uptake of LDL cholesterol from the bloodstream.

**Correct Answer:** C. HMG-CoA acts as an intermediate in the mevalonate pathway, which is involved in the biosynthesis of cholesterol.